Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. [electronic resource]
Producer: 20160425Description: 1805-11 p. digitalISSN:- 1522-9645
- Anti-Arrhythmia Agents -- therapeutic use
- Atrial Fibrillation -- surgery
- Blood Loss, Surgical -- prevention & control
- Catheter Ablation -- adverse effects
- Drug Administration Schedule
- Factor Xa Inhibitors -- administration & dosage
- Female
- Humans
- Male
- Middle Aged
- Operative Time
- Prospective Studies
- Pulmonary Veins -- surgery
- Recurrence
- Reoperation
- Rivaroxaban -- administration & dosage
- Single-Blind Method
- Treatment Outcome
- Vitamin K -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.